Cegedim SA (EPA:ALCGM)
9.80
+0.12 (1.24%)
Nov 12, 2026, 9:16 AM CET
Cegedim Market Cap
Cegedim has a market cap or net worth of €134.87 million as of November 11, 2026. It is the 22,405th most valuable company in the world and the 270th biggest in France. Its market cap has decreased by 20.68% in one year.
Market Cap
134.87M
Enterprise Value
393.96M
Revenue
651.52M
Global Rank
Country Rank
#270 France
PE Ratio
9.86
ChartMarket Cap Chart
Since November 7, 1995, Cegedim's market cap has increased from 113.85M to 134.87M, an increase of 18.47%. That is a compound annual growth rate of 0.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 134.87M | -27.71% |
| Dec 31, 2025 | 186.56M | 6.71% |
| Dec 31, 2024 | 174.83M | -28.22% |
| Dec 29, 2023 | 243.57M | 22.47% |
| Dec 30, 2022 | 198.89M | -39.93% |
| Dec 31, 2021 | 331.11M | -6.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 102.73B |
| EssilorLuxottica Société anonyme | 89.07B |
| Sartorius Stedim Biotech | 22.20B |
| Eurofins Scientific SE | 15.01B |
| Transgene | 199.66M |
| Bastide Le Confort Médical | 144.72M |
| Median Technologies | 137.01M |
| Innate Pharma | 121.25M |